改善老年人抗胆碱能药物处方行为的干预措施的有效性:一项系统评价
Effectiveness of Interventions to Improve the Anticholinergic Prescribing Practice in Older Adults: A Systematic Review.
作者信息
Salahudeen Mohammed S, Alfahmi Adel, Farooq Anam, Akhtar Mehnaz, Ajaz Sana, Alotaibi Saud, Faiz Manal, Ali Sheraz
机构信息
School of Pharmacy and Pharmacology, University of Tasmania, Hobart 7001, Australia.
Department of Pharmacy, East Jeddah General Hospital, Ministry of Health, Jeddah 22253, Saudi Arabia.
出版信息
J Clin Med. 2022 Jan 28;11(3):714. doi: 10.3390/jcm11030714.
BACKGROUND
Pharmacotherapy in older adults is one of the most challenging aspects of patient care. Older people are prone to drug-related problems such as adverse effects, ineffectiveness, underdosage, overdosage, and drug interactions. Anticholinergic medications are associated with poor outcomes in older patients, and there is no specific intervention strategy for reducing drug burden from anticholinergic activity medications. Little is known about the effectiveness of current interventions that may likely improve the anticholinergic prescribing practice in older adults.
AIMS
This review seeks to document all types of interventions aiming to reduce anticholinergic prescribing among older adults and assess the current evidence and quality of existing single and combined interventions.
METHODS
We systematically searched MEDLINE, Embase, Cochrane Central Register of Controlled Trials, CINAHL, and PsycINFO from January 1990 to August 2021. Only studies that examined the effect of interventions in older people focused on improving compliance with anticholinergic prescribing guidelines with quantifiable data were included. The primary outcome of interest was to find the effectiveness of interventions that enhance the anticholinergic prescribing practice in older adults.
RESULTS
We screened 3168 records and ended up in 23 studies that met the inclusion criteria. We found only single-component interventions to reduce anticholinergic prescribing errors in older people. Pharmacists implemented interventions without collaboration in nearly half of the studies ( = 11). Medication review (43%) and education provision (26%) to healthcare practitioners were the most common interventions. Sixteen studies (70%) reported significant reductions in anticholinergic prescribing errors, whereas seven studies (30%) showed no significant effect.
CONCLUSION
This systematic review suggests that healthcare practitioner-oriented interventions have the potential to reduce the occurrence of anticholinergic prescribing errors in older people. Interventions were primarily effective in reducing the burden of anticholinergic medications and assisting with deprescribing anticholinergic medications in older adults.
背景
老年患者的药物治疗是患者护理中最具挑战性的方面之一。老年人容易出现与药物相关的问题,如不良反应、无效、剂量不足、过量以及药物相互作用。抗胆碱能药物与老年患者的不良结局相关,且尚无减少抗胆碱能活性药物负担的具体干预策略。对于当前可能改善老年患者抗胆碱能处方行为的干预措施的有效性,人们了解甚少。
目的
本综述旨在记录旨在减少老年患者抗胆碱能处方的所有类型干预措施,并评估现有单一及联合干预措施的当前证据和质量。
方法
我们系统检索了1990年1月至2021年8月期间的MEDLINE、Embase、Cochrane对照试验中央注册库、CINAHL和PsycINFO。仅纳入那些研究了针对老年人的干预措施效果且聚焦于通过可量化数据提高抗胆碱能处方指南依从性的研究。感兴趣的主要结局是找出增强老年患者抗胆碱能处方行为的干预措施的有效性。
结果
我们筛选了3168条记录,最终纳入了23项符合纳入标准的研究。我们发现仅有单一组分干预措施可减少老年人抗胆碱能处方错误。在近一半的研究(n = 11)中,药剂师独自实施干预措施。对医疗保健从业者进行药物审查(43%)和提供教育(26%)是最常见的干预措施。16项研究(70%)报告抗胆碱能处方错误显著减少,而7项研究(30%)显示无显著效果。
结论
本系统综述表明,以医疗保健从业者为导向的干预措施有可能减少老年人抗胆碱能处方错误的发生。这些干预措施在主要在减轻老年患者抗胆碱能药物负担以及协助停用抗胆碱能药物方面有效。
相似文献
J Am Med Dir Assoc. 2020-2
Ther Adv Drug Saf. 2021-5-31
Cochrane Database Syst Rev. 2013-2-28
Int J Clin Pharm. 2021-12
引用本文的文献
Basic Clin Pharmacol Toxicol. 2025-10
J Clin Med. 2022-8-4
Int J Environ Res Public Health. 2022-3-14
本文引用的文献
Scand J Prim Health Care. 2021-6
Eur J Hosp Pharm. 2020-7
Front Neurosci. 2019-12-6
Eur J Clin Pharmacol. 2020-3